These results suggest a CCL21-induced pro-survival response of pancreatic cancer cells; however, downregulation of AKT1, FOS and JUN and angiogenic cytokines indicates the anti-proliferation effects of CCL21, which somewhat complicates the mechanism of action [150]. The gene discussed is CCL21; the disease is familial pancreatic carcinoma.